🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — need advice Page 4

Pancreatitis risk assessment — need advice

nick_newbie Thu, May 30, 2024 at 12:20 AM 63 replies 3,076 viewsPage 4 of 13
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
May 31, 2024 at 8:56 AM#16

From the other side of the consultation, briefly. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

20 18wei_SG, cory_ATX, lori_vegas and 17 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
May 31, 2024 at 12:21 PM#17

One concrete data point for the thread. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Last edited: May 31, 2024 at 1:21 PM
21 19mike_nyc, VendorMark, COA_Karl and 18 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
May 31, 2024 at 3:45 PM#18

A narrower follow-up, since the general answer is now clear:

What would you measure differently if you were starting again?

Last edited: May 31, 2024 at 8:45 PM
22 20MariaRD, AussieAnna, BethLabQueen and 19 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
May 31, 2024 at 7:09 PM#19
DataDave said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

Happy to go further on any of that.

Last edited: May 31, 2024 at 9:09 PM
23 21TomTeleRx, DoseLogDan, SleepFixSam and 20 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 31, 2024 at 10:33 PM#20

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again.

45 18PurityPaulOR, MaxMetOK, MounjBrad and 42 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register